APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Epoprostenol Sodium

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Epoprostenol Sodium Market Outlook and Growth Opportunities 2026

Report ID 173989060420 December 2025194 pages

Choose your research edition.

Industry ResearchEpoprostenol Sodium Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Epoprostenol Sodium Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Epoprostenol Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Epoprostenol Sodium Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Epoprostenol Sodium Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Epoprostenol Sodium market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Epoprostenol Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Epoprostenol Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Epoprostenol Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Epoprostenol Sodium market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Epoprostenol Sodium market include Ausun Pharmaceutical, Cayman Pharma, Yonsung Fine Chemicals, Pfizer CentreOne, Sanofi and Sun Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Epoprostenol Sodium market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Epoprostenol Sodium and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Epoprostenol Sodium sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Epoprostenol Sodium market size, projected growth trends, production technologies, key applications, and end-use industries.

Epoprostenol Sodium Segment by Company

Ausun Pharmaceutical

Cayman Pharma

Yonsung Fine Chemicals

Pfizer CentreOne

Sanofi

Sun Pharmaceutical

Epoprostenol Sodium Segment by Type

Purity Above 98%

Purity Below 98%

Epoprostenol Sodium Segment by Application

Injection

Other

Epoprostenol Sodium Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Epoprostenol Sodium status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Epoprostenol Sodium market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Epoprostenol Sodium significant trends, drivers, influence factors in global and regions.

6. To analyze Epoprostenol Sodium competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epoprostenol Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Epoprostenol Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epoprostenol Sodium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Epoprostenol Sodium market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Epoprostenol Sodium industry.

Chapter 3: Detailed analysis of Epoprostenol Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Epoprostenol Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Epoprostenol Sodium in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Epoprostenol Sodium Industry Trends Table 2. Epoprostenol Sodium Industry Drivers Table 3. Epoprostenol Sodium Industry Opportunities and Challenges Table 4. Epoprostenol Sodium Industry Restraints Table 5. Global Epoprostenol Sodium Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Epoprostenol Sodium Revenue Share by Company (2021-2026) Table 7. Global Epoprostenol Sodium Sales Volume by Company (tons) & (2021-2026) Table 8. Global Epoprostenol Sodium Sales Volume Share by Company (2021-2026) Table 9. Global Epoprostenol Sodium Average Price (US$/kg) of Company (2021-2026) Table 10. Global Epoprostenol Sodium Company Ranking, (2024-2026) & (USD Million) Table 11. Global Epoprostenol Sodium Key Company Manufacturing Base & Headquarters Table 12. Global Epoprostenol Sodium Company, Product Type & Application Table 13. Global Epoprostenol Sodium Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Epoprostenol Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Purity Above 98% Table 18. Significant Companies of Purity Below 98% Table 19. Global Epoprostenol Sodium Sales Volume by Type 2021 VS 2025 VS 2032 (tons) Table 20. Global Epoprostenol Sodium Sales Volume by Type (2021-2026) & (tons) Table 21. Global Epoprostenol Sodium Sales Volume by Type (2027-2032) & (tons) Table 22. Global Epoprostenol Sodium Sales Volume Share by Type (2021-2026) Table 23. Global Epoprostenol Sodium Sales Volume Share by Type (2027-2032) Table 24. Global Epoprostenol Sodium Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Epoprostenol Sodium Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Epoprostenol Sodium Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Epoprostenol Sodium Sales Value Share by Type (2021-2026) Table 28. Global Epoprostenol Sodium Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Injection Table 30. Significant Companies of Other Table 31. Global Epoprostenol Sodium Sales Volume by Application 2021 VS 2025 VS 2032 (tons) Table 32. Global Epoprostenol Sodium Sales Volume by Application (2021-2026) & (tons) Table 33. Global Epoprostenol Sodium Sales Volume by Application (2027-2032) & (tons) Table 34. Global Epoprostenol Sodium Sales Volume Share by Application (2021-2026) Table 35. Global Epoprostenol Sodium Sales Volume Share by Application (2027-2032) Table 36. Global Epoprostenol Sodium Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Epoprostenol Sodium Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Epoprostenol Sodium Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Epoprostenol Sodium Sales Value Share by Application (2021-2026) Table 40. Global Epoprostenol Sodium Sales Value Share by Application (2027-2032) Table 41. Global Epoprostenol Sodium Sales by Region: 2021 VS 2025 VS 2032 (tons) Table 42. Global Epoprostenol Sodium Sales by Region (2021-2026) & (tons) Table 43. Global Epoprostenol Sodium Sales Market Share by Region (2021-2026) Table 44. Global Epoprostenol Sodium Sales by Region (2027-2032) & (tons) Table 45. Global Epoprostenol Sodium Sales Market Share by Region (2027-2032) Table 46. Global Epoprostenol Sodium Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Epoprostenol Sodium Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Epoprostenol Sodium Sales Value Share by Region (2021-2026) Table 49. Global Epoprostenol Sodium Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Epoprostenol Sodium Sales Value Share by Region (2027-2032) Table 51. Global Epoprostenol Sodium Market Average Price (US$/kg) by Region (2021-2026) Table 52. Global Epoprostenol Sodium Market Average Price (US$/kg) by Region (2027-2032) Table 53. Global Epoprostenol Sodium Sales by Country: 2021 VS 2025 VS 2032 (tons) Table 54. Global Epoprostenol Sodium Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Epoprostenol Sodium Sales by Country (2021-2026) & (tons) Table 56. Global Epoprostenol Sodium Sales Market Share by Country (2021-2026) Table 57. Global Epoprostenol Sodium Sales by Country (2027-2032) & (tons) Table 58. Global Epoprostenol Sodium Sales Market Share by Country (2027-2032) Table 59. Global Epoprostenol Sodium Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Epoprostenol Sodium Sales Value Market Share by Country (2021-2026) Table 61. Global Epoprostenol Sodium Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Epoprostenol Sodium Sales Value Market Share by Country (2027-2032) Table 63. Ausun Pharmaceutical Company Information Table 64. Ausun Pharmaceutical Business Overview Table 65. Ausun Pharmaceutical Epoprostenol Sodium Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 66. Ausun Pharmaceutical Epoprostenol Sodium Product Portfolio Table 67. Ausun Pharmaceutical Recent Development Table 68. Cayman Pharma Company Information Table 69. Cayman Pharma Business Overview Table 70. Cayman Pharma Epoprostenol Sodium Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 71. Cayman Pharma Epoprostenol Sodium Product Portfolio Table 72. Cayman Pharma Recent Development Table 73. Yonsung Fine Chemicals Company Information Table 74. Yonsung Fine Chemicals Business Overview Table 75. Yonsung Fine Chemicals Epoprostenol Sodium Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 76. Yonsung Fine Chemicals Epoprostenol Sodium Product Portfolio Table 77. Yonsung Fine Chemicals Recent Development Table 78. Pfizer CentreOne Company Information Table 79. Pfizer CentreOne Business Overview Table 80. Pfizer CentreOne Epoprostenol Sodium Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 81. Pfizer CentreOne Epoprostenol Sodium Product Portfolio Table 82. Pfizer CentreOne Recent Development Table 83. Sanofi Company Information Table 84. Sanofi Business Overview Table 85. Sanofi Epoprostenol Sodium Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 86. Sanofi Epoprostenol Sodium Product Portfolio Table 87. Sanofi Recent Development Table 88. Sun Pharmaceutical Company Information Table 89. Sun Pharmaceutical Business Overview Table 90. Sun Pharmaceutical Epoprostenol Sodium Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 91. Sun Pharmaceutical Epoprostenol Sodium Product Portfolio Table 92. Sun Pharmaceutical Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Epoprostenol Sodium Distributors List Table 96. Epoprostenol Sodium Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Epoprostenol Sodium Product Image Figure 2. Global Epoprostenol Sodium Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Epoprostenol Sodium Sales Value (2021-2032) & (US$ Million) Figure 4. Global Epoprostenol Sodium Sales (2021-2032) & (tons) Figure 5. Global Epoprostenol Sodium Sales Average Price (US$/kg) & (2021-2032) Figure 6. Global Epoprostenol Sodium Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Purity Above 98% Image Figure 10. Purity Below 98% Image Figure 11. Global Epoprostenol Sodium Sales Volume by Type (2021 VS 2025 VS 2032) & (tons) Figure 12. Global Epoprostenol Sodium Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Epoprostenol Sodium Sales Volume Share by Type (2021-2032) Figure 14. Global Epoprostenol Sodium Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Epoprostenol Sodium Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Epoprostenol Sodium Sales Value Share by Type (2021-2032) Figure 17. Injection Image Figure 18. Other Image Figure 19. Global Epoprostenol Sodium Sales Volume by Application (2021 VS 2025 VS 2032) & (tons) Figure 20. Global Epoprostenol Sodium Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Epoprostenol Sodium Sales Volume Share by Application (2021-2032) Figure 22. Global Epoprostenol Sodium Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Epoprostenol Sodium Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Epoprostenol Sodium Sales Value Share by Application (2021-2032) Figure 25. Global Epoprostenol Sodium Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 26. Global Epoprostenol Sodium Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Epoprostenol Sodium Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Epoprostenol Sodium Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Epoprostenol Sodium Sales Value (2021-2032) & (US$ Million) Figure 30. North America Epoprostenol Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Epoprostenol Sodium Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Epoprostenol Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Epoprostenol Sodium Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Epoprostenol Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Epoprostenol Sodium Sales Value (2021-2032) & (US$ Million) Figure 36. South America Epoprostenol Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Epoprostenol Sodium Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Epoprostenol Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Epoprostenol Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Epoprostenol Sodium Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Epoprostenol Sodium Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Purity Above 98%
  • Purity Below 98%
Applications
  • Injection
  • Other
Companies covered
  • Ausun Pharmaceutical
  • Cayman Pharma
  • Yonsung Fine Chemicals
  • Pfizer CentreOne
  • Sanofi
  • Sun Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Epoprostenol Sodium Sales Value (2021-2032)
  4. 1.2.2 Global Epoprostenol Sodium Sales Volume (2021-2032)
  5. 1.2.3 Global Epoprostenol Sodium Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Epoprostenol Sodium Market Dynamics
  1. 2.1 Epoprostenol Sodium Industry Trends
  2. 2.2 Epoprostenol Sodium Industry Drivers
  3. 2.3 Epoprostenol Sodium Industry Opportunities and Challenges
  4. 2.4 Epoprostenol Sodium Industry Restraints
3 Epoprostenol Sodium Market by Company
  1. 3.1 Global Epoprostenol Sodium Company Revenue Ranking in 2025
  2. 3.2 Global Epoprostenol Sodium Revenue by Company (2021-2026)
  3. 3.3 Global Epoprostenol Sodium Sales Volume by Company (2021-2026)
  4. 3.4 Global Epoprostenol Sodium Average Price by Company (2021-2026)
  5. 3.5 Global Epoprostenol Sodium Company Ranking (2024-2026)
  6. 3.6 Global Epoprostenol Sodium Company Manufacturing Base and Headquarters
  7. 3.7 Global Epoprostenol Sodium Company Product Type and Application
  8. 3.8 Global Epoprostenol Sodium Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Epoprostenol Sodium Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Epoprostenol Sodium Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Epoprostenol Sodium Market by Type
  1. 4.1 Epoprostenol Sodium Type Introduction
  2. 4.1.1 Purity Above 98%
  3. 4.1.2 Purity Below 98%
  4. 4.2 Global Epoprostenol Sodium Sales Volume by Type
  5. 4.2.1 Global Epoprostenol Sodium Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Epoprostenol Sodium Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Epoprostenol Sodium Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Epoprostenol Sodium Sales Value by Type
  9. 4.3.1 Global Epoprostenol Sodium Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Epoprostenol Sodium Sales Value by Type (2021-2032)
  11. 4.3.3 Global Epoprostenol Sodium Sales Value Share by Type (2021-2032)
5 Epoprostenol Sodium Market by Application
  1. 5.1 Epoprostenol Sodium Application Introduction
  2. 5.1.1 Injection
  3. 5.1.2 Other
  4. 5.2 Global Epoprostenol Sodium Sales Volume by Application
  5. 5.2.1 Global Epoprostenol Sodium Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Epoprostenol Sodium Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Epoprostenol Sodium Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Epoprostenol Sodium Sales Value by Application
  9. 5.3.1 Global Epoprostenol Sodium Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Epoprostenol Sodium Sales Value by Application (2021-2032)
  11. 5.3.3 Global Epoprostenol Sodium Sales Value Share by Application (2021-2032)
6 Epoprostenol Sodium Regional Sales and Value Analysis
  1. 6.1 Global Epoprostenol Sodium Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Epoprostenol Sodium Sales by Region (2021-2032)
  3. 6.2.1 Global Epoprostenol Sodium Sales by Region: 2021-2026
  4. 6.2.2 Global Epoprostenol Sodium Sales by Region (2027-2032)
  5. 6.3 Global Epoprostenol Sodium Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Epoprostenol Sodium Sales Value by Region (2021-2032)
  7. 6.4.1 Global Epoprostenol Sodium Sales Value by Region: 2021-2026
  8. 6.4.2 Global Epoprostenol Sodium Sales Value by Region (2027-2032)
  9. 6.5 Global Epoprostenol Sodium Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Epoprostenol Sodium Sales Value (2021-2032)
  12. 6.6.2 North America Epoprostenol Sodium Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Epoprostenol Sodium Sales Value (2021-2032)
  15. 6.7.2 Europe Epoprostenol Sodium Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Epoprostenol Sodium Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Epoprostenol Sodium Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Epoprostenol Sodium Sales Value (2021-2032)
  21. 6.9.2 South America Epoprostenol Sodium Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Epoprostenol Sodium Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Epoprostenol Sodium Sales Value Share by Country, 2025 VS 2032
7 Epoprostenol Sodium Country-level Sales and Value Analysis
  1. 7.1 Global Epoprostenol Sodium Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Epoprostenol Sodium Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Epoprostenol Sodium Sales by Country (2021-2032)
  4. 7.3.1 Global Epoprostenol Sodium Sales by Country (2021-2026)
  5. 7.3.2 Global Epoprostenol Sodium Sales by Country (2027-2032)
  6. 7.4 Global Epoprostenol Sodium Sales Value by Country (2021-2032)
  7. 7.4.1 Global Epoprostenol Sodium Sales Value by Country (2021-2026)
  8. 7.4.2 Global Epoprostenol Sodium Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Epoprostenol Sodium Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Epoprostenol Sodium Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Epoprostenol Sodium Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Ausun Pharmaceutical
  2. 8.1.1 Ausun Pharmaceutical Company Information
  3. 8.1.2 Ausun Pharmaceutical Business Overview
  4. 8.1.3 Ausun Pharmaceutical Epoprostenol Sodium Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Ausun Pharmaceutical Epoprostenol Sodium Product Portfolio
  6. 8.1.5 Ausun Pharmaceutical Recent Developments
  7. 8.2 Cayman Pharma
  8. 8.2.1 Cayman Pharma Company Information
  9. 8.2.2 Cayman Pharma Business Overview
  10. 8.2.3 Cayman Pharma Epoprostenol Sodium Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Cayman Pharma Epoprostenol Sodium Product Portfolio
  12. 8.2.5 Cayman Pharma Recent Developments
  13. 8.3 Yonsung Fine Chemicals
  14. 8.3.1 Yonsung Fine Chemicals Company Information
  15. 8.3.2 Yonsung Fine Chemicals Business Overview
  16. 8.3.3 Yonsung Fine Chemicals Epoprostenol Sodium Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Yonsung Fine Chemicals Epoprostenol Sodium Product Portfolio
  18. 8.3.5 Yonsung Fine Chemicals Recent Developments
  19. 8.4 Pfizer CentreOne
  20. 8.4.1 Pfizer CentreOne Company Information
  21. 8.4.2 Pfizer CentreOne Business Overview
  22. 8.4.3 Pfizer CentreOne Epoprostenol Sodium Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer CentreOne Epoprostenol Sodium Product Portfolio
  24. 8.4.5 Pfizer CentreOne Recent Developments
  25. 8.5 Sanofi
  26. 8.5.1 Sanofi Company Information
  27. 8.5.2 Sanofi Business Overview
  28. 8.5.3 Sanofi Epoprostenol Sodium Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi Epoprostenol Sodium Product Portfolio
  30. 8.5.5 Sanofi Recent Developments
  31. 8.6 Sun Pharmaceutical
  32. 8.6.1 Sun Pharmaceutical Company Information
  33. 8.6.2 Sun Pharmaceutical Business Overview
  34. 8.6.3 Sun Pharmaceutical Epoprostenol Sodium Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sun Pharmaceutical Epoprostenol Sodium Product Portfolio
  36. 8.6.5 Sun Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Epoprostenol Sodium Value Chain Analysis
  2. 9.1.1 Epoprostenol Sodium Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Epoprostenol Sodium Sales Mode & Process
  6. 9.2 Epoprostenol Sodium Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Epoprostenol Sodium Distributors
  9. 9.2.3 Epoprostenol Sodium Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst